1. Protein Tyrosine Kinase/RTK PI3K/Akt/mTOR Apoptosis
  2. VEGFR Akt Caspase Bcl-2 Family Apoptosis
  3. VEGFR-2/AKT-IN-2

VEGFR-2/AKT-IN-2 (Compound 5) 是一个 VEGFR-2/AKT 抑制剂 (对人肝肿瘤细胞上VEGFR的 IC50 为 0.061 μM)。VEGFR-2/AKT-IN-2 减少细胞中总的和磷酸化AKT,上调 BAXcaspase-3,下调 Bcl-2,从而促进细胞凋亡 (Apoptosis)。VEGFR-2/AKT-IN-2使细胞周期在 S 期停止。VEGFR-2/AKT-IN-2 抑制人肝肿瘤细胞生长。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

VEGFR-2/AKT-IN-2 Chemical Structure

VEGFR-2/AKT-IN-2 Chemical Structure

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

VEGFR-2/AKT-IN-2 (Compound 5) is a VEGFR-2/AKT inhibitor (IC50: 0.061 μM for VEGFRin HepG2 cell). VEGFR-2/AKT-IN-2 reduces total and phosphorylated AKT as well as up-regulates BAX and Caspase-3 and down-regulates Bcl-2 in cells, thereby promoting Apoptosis. VEGFR-2/AKT-IN-2 causes cell cycle arrest in S phase. VEGFR-2/AKT-IN-2 inhibits the growth of human liver tumor cells[1].

IC50 & Target[1]

VEGFR2

0.061 μM (IC50)

Bcl-2

 

Caspase 3

 

体外研究
(In Vitro)

VEGFR-2/AKT-IN-2 具有与索拉非尼 (HY-10201) 相似的 VEGFR2 抑制活性,IC50 为 0.061 μM[1]
VEGFR-2/AKT-IN-2 (0.39-100 μM, 48 h) 抑制 HepG-2 和 HuH-7 细胞系生长,其 IC50 值分别为 0.75 和 3.43 μM[1]
VEGFR-2/AKT-IN-2 (0.75 μM, 48 h) 减少 HepG-2 细胞中总的和磷酸化的 AKT[1]
VEGFR-2/AKT-IN-2 (0.75 μM, 48 h) 促进细胞凋亡,增加早期和晚期凋亡细胞占比 (分别从0.39%增加到26.28%,从0.21%增加到18.87%),上调 BAXcaspase-3,下调 Bcl-2[1]
VEGFR-2/AKT-IN-2 (0.75 μM, 48 h) 阻止 HepG-2 细胞在 S 期的细胞周期进展[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Cytotoxicity Assay[1]

Cell Line: HepG-2, HuH-7, THLE-2
Concentration: 100 μM, 25 μM, 6.25 μM, 1.56 μM, and 0.39 μM.
Incubation Time: 48 h
Result: Inhibited the growth of HepG-2 and HuH-7 cell lines with IC50 of 0.75 μM and 3.43 μM, respectively.

Cell Cycle Analysis[1]

Cell Line: HepG-2
Concentration: 0.75 μM
Incubation Time: 48 h
Result: The cell cycle progression was arrested during the S phase in 48.02% of HepG-2 cells compared to untreated HepG-2 cells (29.66%).
Significantly decreased the proportion of cells in the G2/M phase (58.71%) and increased the proportion of cells in the S phase after 24 h.
分子量

437.49

Formula

C25H16FN5S

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
VEGFR-2/AKT-IN-2
目录号:
HY-169431
需求量: